Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
B0VJ9Q
|
|||
| Binder Name |
Pazopanib
|
|||
| Synonyms |
GW786034; UNII-7RN5DR86CK; Pazopanib (GW-786034); 7RN5DR86CK; GW 78603; MFCD11616589; GW 786034; NCGC00188865-01; DSSTox_CID_28659; DSSTox_RID_82929; DSSTox_GSID_48733; GW-786034; C21H23N7O2S; Pazopanib [INN:BAN]; pazopanibum; HSDB 8210; indazolylpyrimidine 13; Pazopanib (free base); Kinome_3790; PubChem22448; GW7 86034; Pazopanib/GW-786034; SCHEMBL588608; CHEMBL477772; GTPL5698; JMC514632 Compound 13; DTXSID8048733; BDBM26474; QCR-110; SYN1058; cid_10113978; BCPP000129; HMS3244C21; HMS3244C22; HMS3244D21; HMS3656L14; HMS3745G05; AOB87179; BCP01839; EX-A1241; Tox21_113174; ABP000868; ABP000882; NSC752782; s3012; ZINC11617039; AKOS005145819; Tox21_113174_1; AC-8522; BCP9001053; CCG-265010; CS-0269; DB06589; MCULE-2193898201; NSC-752782; SB17290; NCGC00188865-02; NCGC00188865-03; NCGC00188865-10; AS-11066; HY-10208; SC-23290; AB0008634; AM20090659; FT-0659928; FT-0684794; SW218082-3; Pazopanib Hydrochloride /GW786034,VOTRIENT; A11518; A19406; P-6706; Q-1426; S-7750; AB01273967-01; AB01273967-02; AB01273967_05; AB01273967_06; A839572; AR-270/43507999; Q-101400; Q7157043; BRD-K74514084-003-02-7; Z1541638525
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H23N7O2S
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
|
|||
| InChI |
1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)
|
|||
| InChIKey |
CUIHSIWYWATEQL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:71219
|
|||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.